HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity-Reference-Cited by-同舟云学术

HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity

Published:2009-11 Issue:1 Volume:140 Page:18-26
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Etrych Tomáš,Strohalm Jiří,Kovář Lubomír,Kabešová Martina,Říhová Blanka,Ulbrich Karel

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Macromolecular carriers for drug targeting;Schacht,1996

2. Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physico-chemical characterisation;Ulbrich;J. Control. Release,2000

3. Polymer conjugates as anticancer nanomedicines;Duncan;Natl. Rev. Cancer,2006

4. Prodrug strategies in anticancer chemotherapy;Kratz;ChemMedChem,2008

5. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anticancer activity of Ab or (Fab′)2-targeted conjugates and combined theraphy with immunomodulators;Říhová;J. Control. Release,2000

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid Macromolecular Constructs as a Platform for Spectral Nanoprobes for Advanced Cellular Barcoding in Flow Cytometry;Macromolecular Bioscience;2023-09-24

2. Recent Updates on Folate Targeted Drug Delivery Systems in Cancer: A Mini Review;Current Cancer Therapy Reviews;2023-02

3. Protein-based nanomaterials: a new tool for targeted drug delivery;Therapeutic Delivery;2022-06

4. Diazido macrocyclic sulfates as a platform for the synthesis of sequence-defined polymers for antibody drug conjugates;Chemical Science;2022

5. Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab;Journal of Controlled Release;2020-12